share_log

JMP Securities Initiates Coverage On Werewolf Therapeutics With Market Outperform Rating, Announces Price Target of $12

JMP Securities Initiates Coverage On Werewolf Therapeutics With Market Outperform Rating, Announces Price Target of $12

JMP证券以市场跑赢大盘的评级启动对狼人疗法的报道,宣布目标股价为12美元
Moomoo 24/7 ·  04/03 04:47

JMP Securities analyst Reni Benjamin initiates coverage on Werewolf Therapeutics (NASDAQ:HOWL) with a Market Outperform rating and announces Price Target of $12.

JMP证券分析师雷尼·本杰明以市场跑赢大盘的评级启动了对狼人疗法(纳斯达克股票代码:HOWL)的报道,并宣布目标股价为12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发